Bloomberg Law Reports
Anti‐Commercial Bribery Laws in China and Their Enforcement in the Pharmaceutical Industry
November 2010
Anti‐commercial bribery laws have a huge impact on the daily business operation of companies in China. At present, relevant laws and regulations in China are very general and vague and, as a result, enforcement agencies at local levels have a great deal of discretion in determining what types of activities constitute commercial bribery, and what penalties will be imposed.
得意分野
Suggested News & Insights
DOJ Announces FOCUS Initiative to Work with Data Miners Filing Qui TamsApril 30, 2026New Guidance on U.S. Procurement Raises Risk to Federal Contractors From Potentially Discriminatory PracticesApril 29, 2026April Antitrust and Competition Bulletin: Top-of-Mind Global Antitrust IssuesApril 27, 2026Seventh Circuit Orders Release of Sidley ClientApril 24, 2026Clayton Addresses the Uncertainty Surrounding SDNY’s Self-Disclosure ProgramApril 23, 2026Evolving AML/CFT Expectations and Enforcement Priorities as FinCEN Releases FY 2025 Year in ReviewApril 22, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory